This paper examines endometrial adenocarcinoma, the most common gynecologic malignancy in postmenopausal women. It discusses the anatomical basis of the disease, major risk factors including hormonal imbalances and metabolic conditions, and the diagnostic importance of endometrial complex atypical hyperplasia (CAH) as a precursor lesion. The paper details diagnostic procedures such as dilatation and curettage (D&C) and FIGO staging, explains treatment approaches ranging from hysterectomy with bilateral salpingo-oophorectomy to adjunctive radiation therapy for cases with deep myometrial invasion, and provides prognosis data based on FIGO stage classification. The analysis emphasizes the critical role of accurate staging and pathological assessment in determining optimal treatment and predicting five-year survival rates.
Within the past fifty years, Pap smears have played a vital role in the decrease of cervical cancer incidence and mortality. However, the test itself is highly subjective, with a limited sensitivity of 50% along with a number of inherent individual variability. This limited sensitivity extends to other cancers, including endometrial adenocarcinoma. Endometrial adenocarcinoma is the most common gynecologic cancer diagnosed in the United States, affecting postmenopausal women predominantly. With the case study purporting the existence of abnormal cells diagnosed as endometrial adenocarcinoma, it is safe to assume that the woman in question was experiencing other symptomatology accompanying the diagnostic findings.
Endometrial cancer develops within the lining of the uterus, known as the endometrium, which thickens monthly in preparation for pregnancy and is shed subsequently during menstruation. Three types of endometrial cancer exist: adenocarcinoma, papillary serous carcinoma, and clear cell adenocarcinoma. Adenocarcinoma is the predominant form, developing on the surface of the endometrium and accounting for 90% of all cases, with abnormal bleeding presenting as a common symptom.
The cause of endometrial cancer is unknown; however, a number of risk factors are associated with the disease and may point to an oncogenic source. Hormone levels significantly influence endometrial cancer development, particularly in peri- and postmenopausal women where hormone fluctuations can lead to increased estrogen production, which has been linked to cancer development. Additional risk factors include increasing age, metabolic syndromes such as obesity and diabetes, long-term use of tamoxifen, hormone replacement therapy, and having a first-degree relative afflicted with the disease.
A known precursor to adenocarcinoma is endometrial complex atypical hyperplasia (CAH), which carries a 25% chance of oncogenesis. The treatment for CAH, as with adenocarcinoma, is usually hysterectomy, although it can benefit from progestational treatment. Management of CAH is difficult due to the inherent inconsistencies in lesion classification, natural history, and histologic diagnosis. The patient in question will require further endometrial sampling analyzed and given an International Federation of Gynecology and Obstetrics (FIGO) score, usually through a biopsy under anesthesia called a D&C, with adenocarcinoma appearing as squamous differentiation under microscopy.
Accurate diagnosis and staging are critical for determining treatment and predicting patient outcomes. The FIGO staging system evaluates the extent of myometrial invasion, histological type, and differentiation grade. A FIGO score provides essential prognostic information that guides clinical decision-making. The depth of tumor invasion into the myometrial muscle is particularly important, as it influences whether additional lymph node assessment and radiation therapy are warranted. Pathological examination must also assess peritoneal cytology and the presence or absence of vascular space invasion, as these factors affect treatment intensity and staging classification.
You’re 62% through this paper. Sign up to read the full paper.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.